Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. [1] [2] [3] [4] He succeeded Joseph Jimenez who left Novartis in 2018. [5]

Jan 31, 2024 · Since becoming CEO of Novartis in 2018, Vas has led a strategic and cultural transformation to build a fully focused medicines company—one that delivers high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.

Vasant “Vas” Narasimhan is an American physician of Indian origin who was named the Chief Executive Officer (CEO) of Novartis International AG, a Swiss multinational pharmaceutical company, in September 2017. He is expected to replace Joseph Jimenez, the incumbent CEO, in …

Jan 9, 2024 · Novartis CEO Vasant Narasimhan joins 'Money Movers' to discuss the company's overall M&A strategy, the businesses that Narasimhan wanted to get out of, and how big the Entresto drug can be.

Feb 8, 2023 · Dr. Narasimhan has been CEO of Novartis since 2018, leading the company in delivering medicines that alleviate some of society’s greatest disease burdens through novel access approaches and technology leadership in R&D.

Aug 2, 2019 · Vas Narasimhan had held down various senior exec roles at Novartis before taking the reins in February 2018. He thought his previous experience had well prepared him for the top job—until he...

Apr 12, 2024 · The 47-year-old CEO, who was in Hyderabad last fortnight—Novartis’s largest hub outside its headquarters in Switzerland—met up with Manu Balachandran and explained how, and why, the drug ...

Jan 22, 2025 · Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s commitment to India despite the domestic pharmaceutical market's relatively smaller size compared to ...

Vasant (Vas) Narasimhan, M.D., has been Chief Executive Officer (CEO) of Novartis since February 1, 2018. Dr. Narasimhan previously was Global Head of Drug Development and Chief Medical Officer for Novartis.